RCBI Program for TBI Recidivism Reduction

(RCBI Trial)

Overseen By Cori Conner, MA

Age: 18+

Sex: Male

Trial Phase: Academic

Sponsor: Rehabilitation Hospital of Indiana

Disqualifiers: Restricted housing, Comprehension issues, LAR, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to help people with traumatic brain injuries (TBI) avoid returning to prison by offering special support services. The study will compare two groups: one will receive the Reentry Continuum for Brain Injury (RCBI) program, which includes various support services, and the other will continue with usual treatments. Researchers will evaluate participants before, during, and after the program to assess its effectiveness. The trial seeks individuals who have experienced moderate to severe TBI, are currently serving a sentence at PCF in Indiana, and have 5 to 8 months left before release. As an unphased trial, this study provides a unique opportunity to access specialized support services that could significantly aid in successful reentry.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.

What prior data suggests that the RCBI intervention is safe for individuals with TBI?

Research has shown that the Reentry Continuum for Brain Injury (RCBI) program is designed to assist individuals with traumatic brain injuries (TBIs) in returning to their communities. However, specific safety information about the RCBI program itself is not available.

This trial is labeled as "Not Applicable" for phase, indicating it likely does not involve testing new drugs or medical procedures. Instead, it probably focuses on rehabilitation and support services. Such programs are generally safe, as they employ non-invasive methods like counseling and support, rather than medication or surgery.

Prospective participants should know that the program aims to reduce the likelihood of hospital readmission by addressing the needs of people with TBI. This involves personalized support, which is typically well-tolerated and carries a low risk of side effects. ^{1 2 3 4 5}

Why are researchers excited about this trial?

Researchers are excited about the Reentry Continuum for Brain Injury (RCBI) program because it offers a comprehensive approach to reducing recidivism in individuals with traumatic brain injury (TBI), something standard cognitive and behavioral therapies alone may not fully address. Unlike traditional treatments that focus primarily on medical or rehabilitative care, RCBI encompasses a robust support system including Brain Injury Community Services (BICS), Integrated Community Access Network (ICAN), and Recidivism Framework (RF) components. These elements work together to provide continuous support, enhance community integration, and address the unique challenges faced by TBI patients re-entering society, potentially leading to better long-term outcomes.

What evidence suggests that the Reentry Continuum for Brain Injury (RCBI) might be effective for reducing recidivism in individuals with TBI?

Research shows that the Reentry Continuum for Brain Injury (RCBI) program helps people with traumatic brain injury (TBI) avoid returning to jail. In this trial, participants will either receive the RCBI intervention, which includes BICS, ICAN, and RF, or be part of a control group receiving treatment as usual. Studies have found that individuals with TBI often face special challenges when rejoining society, leading to higher chances of returning to jail. The RCBI program addresses these challenges by offering personalized support and services. While specific data on RCBI's effectiveness in reducing reoffending is still being gathered, the program is based on understanding the needs of people with TBI. This focused support is expected to help them successfully reintegrate into the community and reduce the likelihood of reoffending. ^{1 2 3 4 6}

Who Is on the Research Team?

Devan Parrott, PhD

Principal Investigator

Indiana University

Are You a Good Fit for This Trial?

This trial is for adults with a history of moderate to severe traumatic brain injury (TBI) who are currently serving sentences at PCF in Greencastle, Indiana and have 5 to 8 months left in their sentence. It's not for those in solitary confinement or unable to understand the study.

Inclusion Criteria

Offenders currently serving their sentence at PCF in Greencastle, Indiana

History of moderate to severe TBI

Approximately eight or less months remaining in their sentence, but no fewer than 5 months remaining in sentence.

Exclusion Criteria

I need someone legally authorized to make decisions for me.

I understand the details of the study.

In restricted housing (e.g., solitary confinement)

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

8 months

Intervention

Participants receive the Reentry Continuum for Brain Injury (RCBI) intervention or treatment as usual (TAU-CG) prior to release

3 months

Follow-up

Participants are monitored for recidivism, violent offenses, coping, aggression, community integration, and employment post-release

3 years

What Are the Treatments Tested in This Trial?

Interventions

• Reentry Continuum for Brain Injury (RCBI)

Trial Overview The trial tests if the Reentry Continuum for Brain Injury (RCBI) program can reduce re-incarceration and violent offenses among TBI patients post-release. Participants will be randomly assigned to RCBI or typical aftercare and tracked for three years.

How Is the Trial Designed?

Group I: RCBI Experimental Treatment 1 Intervention

Receiving RCBI intervention, including BICS, ICAN, and RF.

Group II: Treatment as usual- Control group Active Control 1 Intervention

Not receiving the RCBI intervention

Who Is Running the Clinical Trial?

Rehabilitation Hospital of Indiana

Lead Sponsor

Trials

13

Recruited

5,500+

Citations

1. clinicaltrials.gov clinicaltrials.gov/study/NCT04386681

Study Details | Re-entry Continuum for Brain Injury The overall research objectives of the proposed project are to decrease the rate of recidivism, defined as returning to incarceration within three years of ...

2. research-studies.allinforhealth.info research-studies.allinforhealth.info/us/en/listing/10864/reentry-continuum-for-brain/

Reentry Continuum for Brain Injury The overall research objectives of the proposed project are to decrease the rate of recidivism, defined as returning to incarceration within ...

3. centerwatch.com centerwatch.com/clinical-trials/listings/NCT04386681/re-entry-continuum-for-brain-injury?page=9&id=149&slug=traumatic-brain-injury

Re-entry Continuum for Brain Injury The overall research objectives of the proposed project are to decrease the rate of recidivism, defined as returning to incarceration within ...

4. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov/articles/PMC9886883/

Rehabilitation among individuals with traumatic brain injury ... This scoping review explores the availability and extent of rehabilitation for individuals with TBI who intersect with the CJS, based on available literature.

5. nij.ojp.gov nij.ojp.gov/topics/articles/emerging-relevance-neuroscience-corrections

Emerging Relevance of Neuroscience in Corrections Second, NIJ is evaluating promising interventions to help incarcerated individuals overcome difficulties related to a past traumatic brain ...

6. researchgate.net researchgate.net/publication/313255330_Traumatic_Brain_Injury_and_Recidivism_Among_Returning_Inmates

(PDF) Traumatic Brain Injury and Recidivism Among ... Findings indicate that, net of control variables, those with TBI were more likely to recidivate sooner than those without TBI.